Physician profile
William E Faragher
NPI 1699710087
$801.86
in general payments reported to CMS, 2019-2025
8 companies · $23.17 in 2025
The $23.17 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $126 · 2021: $148 · 2022: $352 · 2023: $13.40 · 2024: $140 · 2025: $23.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $386.82 | 2021-2024 | |
| Avanos Medical | $142.67 | 2022 | |
| Allergan, INC. | $106.53 | 2020 | |
| Bioventus LLC | $61.26 | 2020-2025 | Xcell, Durolane |
| Biohaven Pharmaceuticals, INC. | $35.64 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $35.51 | 2022 | |
| Alliance Medical | $20.03 | 2024 | |
| Depuy Synthes Sales INC. | $13.40 | 2023 | Peak, Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Faragher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.